Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objectives: To investigate HIV-DNA and residual viremia (RV) levels over 96 weeks (W96) in virologically-suppressed HIV-1-infected individuals enrolled in the Be-OnE Study. Individuals were randomised to continue a two-drug regimen with dolutegravir (DTG) plus one reverse transcriptase inhibitor (RTI) or to switch to elvitegravir/cobicistat/emtricitabine/tenofovir-alafenamide (E/C/F/TAF).
Study Design: Total HIV-DNA and RV were evaluated at baseline, W48 and W96 using droplet digital polymerase chain reaction (ddPCR) technique. Potential relationships between viro-immunological parameters and between/within arms were also assessed.
Results: Median (interquartile range [IQR]) HIV-DNA was 2247 (767-4268), 1587 (556-3543) and 1076 (512-2345) copies/10 CD4+T-cells at baseline, W48 and at W96, respectively; RV was 3 (1-5), 4 (1-9) and 2 (2-4) copies/mL, respectively, with no significant differences between arms. A significant reduction in HIV-DNA and RV from baseline to W96 was observed in the E/C/F/TAF arm (HIV-DNA: -285 [-2257; -45], P=0.010; RV: -1 [-3;0], P=0.007). In the DTG + 1 RTI arm, HIV-DNA and RV levels remained stable (HIV-DNA: -549 [-2269;+307], P=0.182; RV: -1 [-3;+1], P=0.280). For both HIV-DNA and RV, there were no significant changes over time between the arms. A positive correlation was found between baseline HIV-DNA and HIV-DNA at W96 (E/C/F/TAF: Spearman correlation coefficient (r)=0.726, P=0.0004; DTG + 1 RTI: r=0.589, P=0.010). In general, no significant correlations were found between HIV-DNA, RV and immunological parameters over time.
Conclusions: In virologically-suppressed individuals, there was a small reduction in HIV-DNA and HIV-RNA levels from baseline to W96 in individuals who switched to the E/C/F/TAF arm compared with those who remained on DTG + 1 RTI. However, there were no significant differences between the two arms in the changes in HIV-DNA and HIV-RNA over time.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijantimicag.2023.106771 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impacts of immune checkpoint inhibitors use on the HIV reservoir are linked to provirus sequences but not integration sites.
Sci Rep
August 2025
Sorbonne University, INSERM, Pierre Louis Institute of Epidemiology and Public Health, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Laboratoire de Virologie, Paris, 75013, France.
Antibodies to programmed cell death 1 (PD-1), Programmed death-ligand 1 (PDL-1) and Cytotoxic-T-lymphocyte-associated protein 4 (CTLA-4) can revert HIV latency and enhance anti-HIV cytotoxic response but their impact on HIV proviral sequences and integration landscape in people with HIV (PWH) remain to be studied. Two PWH treated with PD-1/PDL-1 and one with PD-1/CTLA4 were studied among the ANRS-CO-24 OncoVIHAC cohort study. Matched integration site and proviral sequencing were performed pre- and post-treatment.
View Article and Find Full Text PDFDuplex digital PCR assay on microfluidic chamber arrays for total HIV DNA reservoir quantification in persons with HIV.
Sci Rep
August 2025
HIV/AIDS and Infectious Diseases Research Group, Hospital La Paz Institute for Health Research (IdiPAZ), Paseo de la Castellana 261, 28046, Madrid, Spain.
HIV reservoir latently persists in people with HIV (PWH) despite long-term antiretroviral therapy (ART). Total HIV DNA quantification is commonly employed as a surrogate marker to assess the size of the viral reservoir. We developed a duplex digital PCR assay to easily quantify the total HIV DNA in PWH on the microfluidic automated Absolute Q™ digital PCR platform.
View Article and Find Full Text PDFNo associations between HIV reservoir and inflammation in long-term virally suppressed dolutegravir-based ART-treated individuals.
Front Immunol
August 2025
Immunology and Infectious Diseases Laboratory, Grappe Interdisciplinaire de Génoprotéomique Appliquée (GIGA)-Institute, University of Liège, Liège, Belgium.
Introduction: Despite effective antiretroviral therapy (ART), people with HIV (PWH) experience persistent immune activation and inflammation, increasing the risk of non-AIDS-related comorbidities. The contribution of the HIV reservoir to this chronic inflammatory state remains debated. Understanding the relationship between HIV persistence, immune activation, and inflammation is crucial for optimizing long-term therapeutic strategies.
View Article and Find Full Text PDFLimitations and use of the Morpheus-V5 dual reporter virus in assessing interventions that target HIV latency.
J Virol Methods
December 2025
Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospi
HIV can persist indefinitely in latently infected CD4 + T-cells as an integrated provirus with limited or no viral transcription and expression of viral proteins. We further characterised a recently described dual reporter virus, Morpheus-V5, that expresses murine heat-stable antigen and mCherry in productively infected cells (which is HIV LTR dependent) and V5 and Nerve growth factor receptor (NGFR) in latently infected cells (which is HIV LTR independent). We demonstrated successful infection of resting and activated CD4 + T-cells using Morpheus-V5 pseudotyped with either X4, R5 or dual tropic envelope proteins.
View Article and Find Full Text PDFNumerical analysis of WS/SiN for improved SPR-based HIV DNA detection.
Front Bioeng Biotechnol
July 2025
INFN-Laboratori Nazionali di Frascati, Frascati, Italy.
Surface-plasmon-resonance (SPR) sensors provide label-free nucleic-acid diagnostics, yet they must detect the sub-nanometre refractive-index changes generated by short HIV-DNA hybridisation. Using a transfer-matrix framework, we design a multilayer architecture that couples a 50 nm silver mirror to the analyte through a 7 nm (10 nm) silicon-nitride spacer capped with a monolayer of WS. This impedance-matched stack (Sys) concentrates the evanescent field at the recognition surface while chemically passivating the metal.
View Article and Find Full Text PDF